Icon

XOSPATA (nda211349)- (EQ 40MG BASE)

GILTERITINIB FUMARATE ASTELLAS
EQ 40MG BASE
Yes No
2036-Jul-01 2023-Nov-28
None None
None No
XOSPATA is a kinase inhibitor indicated for the treatment of adult patients who have relapsed or refractory acute myeloid leukemia (AML) with a FLT3 mutation as detected by an FDA-approved test.
0 1 0
Total Other Developers None
Drugs with Suitability No
EQ 40MG BASE ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.